Madrigal pharmaceuticals appoints ronald filippo as chief information officer

Conshohocken, pa., nov. 21, 2023 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today announced that ronald filippo has been appointed chief information officer.

MDGL Ratings Summary

MDGL Quant Ranking